ONLINE PHARMACY BUSINESS PLAN

I. Executive Summary

Company Description

NovaRx (Nova meaning new, Rx meaning prescription) is a U.S.-based modern digital pharmacy launching in 2026 that combines secure e-commerce with licensed pharmacist services. We operate in the online pharmacy and healthcare fulfillment sector and sell prescription medications, over-the-counter health products, specialty therapies, and subscription medication management. Our platform pairs a HIPAA-ready checkout and telepharmacy consultations with a centralized fulfillment center to reduce overhead and shorten delivery times. One-liner: NovaRx delivers prescriptions and care digitally, securely, and quickly.

We run a centralized fulfillment model with licensed pharmacists on staff, an integrated logistics network for discreet nationwide delivery, and a SaaS-driven customer portal for refill automation and adherence tracking. What sets us apart is the combination of professional pharmacy oversight, a single fulfillment hub to control quality and margin, and a UX designed for chronically medicated adults and caregivers seeking convenience and privacy. Short-term goals: pass all regulatory checks, launch operations in Q1 2026, and onboard pharmacy partners and payer relationships. Long-term goals: achieve unit-level profitability, expand specialty and chronic care programs, and integrate with major telehealth platforms. One-liner: We scale margin and reach through centralized fulfillment and clinical integration.

Problem

Busy and immobile patients face time and access barriers to pharmacy care: travel, waiting, limited hours, and poor digital integration reduce consistent medication adherence, complicate caregiver coordination, and fail to protect privacy for sensitive therapies. The current retail pharmacy model does not provide seamless e-commerce, discreet delivery, or centralized care coordination demanded by modern healthcare consumers.

The gap requires a new model that combines secure online ordering with professional pharmacy services and centralized fulfillment; we will launch a U.S. full-service digital pharmacy in 2026 to fill that need and restore reliable, fast, and discreet nationwide delivery.

Solution

One-line: A HIPAA-compliant web and mobile platform that manages prescriptions end-to-end—upload, consult, insure, refill, and deliver. This addresses long wait times, travel barriers, poor digital integration, and lack of on-demand pharmacist support that reduce adherence for busy professionals, caregivers, mobility-challenged patients, and those with chronic conditions.

The platform lets users upload prescriptions, enroll in automated refills, consult licensed pharmacists via private chat, integrate claims with insurers, sync with telehealth for e-prescription fulfillment, and coordinate discreet home delivery while offering curated wellness products.

Mission Statement

We deliver prescriptions and health products directly to customers' doors with speed and reliability, replacing the hassle of traditional pharmacy visits with a secure, professional online experience. We improve medication adherence and patient outcomes through practical technology and direct pharmacist support. We aim to be the most trusted digital health partner for busy people and those managing complex conditions, making healthcare accessible, discreet, and integrated into modern life.

Key Success Factors

These factors must hold to deliver margin, growth, and predictable cash flow.

• 60.0% repeat customer rate by 2030 — anchors revenue stability and reduces acquisition pressure.
• Wholesale medication cost 10.0%–12.0% — sustains strong gross margins across categories.
• $1,000,000 marketing budget with $35 CAC — enables scalable customer acquisition and market penetration.
• 36‑month customer lifetime value (CLTV) — provides a predictable, bankable revenue stream.
• Shipping fees at 3.0% of revenue — preserves competitive pricing and supports fast delivery.

Financial Summary

Brief financial snapshot: the venture breaks even in Feb‑2027, with rapid EBITDA growth to Year 5.

Financial requirements: $380,000 first‑year capex; minimum cash required $171,000 (needed by Feb‑2027); payback 26 months; overall IRR 11% and ROE 66.86%.

Overall outlook: the plan reaches breakeven in Feb‑2027 and delivers strong equity returns thereafter.

Funding Requirements

Seed round of $551,000 funds $380,000 capex, $150,000 initial marketing, and a $171,000 cash buffer; the venture breaks even in Feb‑2027, Year 1 EBITDA is -$393,000, Year 5 EBITDA is $39,895,000, projected IRR is 11%, ROE is 66.86%, and payback is 26 months.